Get the Stockscreener App
217.32
0.21%
-0.40
Overview
News
Price History
Option Chain
Financials
Why MS Down?
Discussions
Forecast
Stock Split
Dividend History
Morgan Stanley stock is traded at $217.32, with a volume of 1.52M.
It is down -0.21% in the last 24 hours and up +0.43% over the past month.
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 82,000 employees as of year-end 2025. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $9.3 trillion in client assets at the end of 2025. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with more than $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.
See More
Previous Close:
$217.72
Open:
$217.2
24h Volume:
1.52M
Relative Volume:
0.29
Market Cap:
$341.24B
Revenue:
$128.77B
Net Income/Loss:
$20.37B
P/E Ratio:
17.57
EPS:
12.3718
Net Cash Flow:
$39.02B
1W Performance:
+2.95%
1M Performance:
+0.43%
6M Performance:
+35.56%
1Y Performance:
+46.02%
1-Day Range:
$215.22
$218.50
1-Week Range:
$210.60
$218.50
52-Week Range:
$148.35
$232.25
Morgan Stanley Stock (MS) Company Profile
Name
Morgan Stanley
Sector
Industry
Phone
212-761-4000
Address
1585 BROADWAY, NEW YORK, NY
Compare MS vs GS, SCHW, HOOD, IBKR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MS
Morgan Stanley
|
217.27 | 341.94B | 128.77B | 20.37B | 39.02B | 12.37 |
GS
Goldman Sachs Group Inc
|
1,034.93 | 302.41B | 128.57B | 20.97B | 112.72B | 64.79 |
SCHW
Charles Schwab Corp
|
108.03 | 189.00B | 28.33B | 9.42B | 9.76B | 5.0426 |
HOOD
Robinhood Markets Inc
|
119.08 | 109.79B | 4.65B | 1.89B | -2.09B | 2.0676 |
IBKR
Interactive Brokers Group Inc
|
91.54 | 41.96B | 10.76B | 4.56B | 35.82B | 2.326 |
Morgan Stanley Stock (MS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-30-26 | Downgrade | Oppenheimer | Perform → Underperform |
| Apr-27-26 | Upgrade | Erste Group | Hold → Buy |
| Apr-07-26 | Upgrade | UBS | Neutral → Buy |
| Mar-05-26 | Downgrade | Erste Group | Buy → Hold |
| Nov-24-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-03-25 | Initiated | BMO Capital Markets | Outperform |
| Jul-09-25 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Nov-26-24 | Downgrade | HSBC Securities | Buy → Hold |
| Nov-15-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-24 | Downgrade | Goldman | Buy → Neutral |
| Aug-02-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-17-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-17-24 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Jan-09-24 | Downgrade | HSBC Securities | Buy → Hold |
| Nov-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Nov-20-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Oct-23-23 | Downgrade | Odeon | Buy → Hold |
| Oct-20-23 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Oct-11-23 | Downgrade | UBS | Buy → Neutral |
| Sep-07-23 | Initiated | HSBC Securities | Buy |
| Jul-12-23 | Upgrade | Odeon | Hold → Buy |
| Jan-18-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-10-23 | Upgrade | Odeon | Sell → Hold |
| Jan-04-23 | Downgrade | Wolfe Research | Outperform → Underperform |
| Oct-05-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Sep-06-22 | Downgrade | Odeon | Hold → Sell |
| May-03-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jan-28-22 | Downgrade | Odeon | Buy → Hold |
| Dec-03-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-04-21 | Reiterated | Jefferies | Buy |
| Sep-29-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-28-21 | Downgrade | Berenberg | Buy → Hold |
| Aug-13-21 | Downgrade | Seaport Global Securities | Buy → Neutral |
| Jul-07-21 | Resumed | Keefe Bruyette | Outperform |
| Jun-09-21 | Initiated | Jefferies | Buy |
| Apr-21-21 | Upgrade | Berenberg | Hold → Buy |
| Mar-02-21 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jan-06-21 | Initiated | Daiwa Securities | Neutral |
| Jan-04-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-10-20 | Downgrade | Citigroup | Buy → Neutral |
| Oct-13-20 | Resumed | JP Morgan | Overweight |
| Jul-08-20 | Initiated | Seaport Global Securities | Buy |
| Jun-24-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jun-23-20 | Reiterated | UBS | Buy |
| May-21-20 | Upgrade | Odeon | Hold → Buy |
| Apr-14-20 | Upgrade | Societe Generale | Sell → Buy |
| Mar-13-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-04-20 | Upgrade | Citigroup | Neutral → Buy |
| Feb-21-20 | Downgrade | DA Davidson | Buy → Neutral |
| Feb-20-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-21-20 | Downgrade | Citigroup | Buy → Neutral |
| Jan-17-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-13-20 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jan-09-20 | Initiated | DA Davidson | Buy |
| Jan-06-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-29-19 | Downgrade | Odeon | Buy → Hold |
| Oct-10-19 | Upgrade | Sandler O'Neill | Hold → Buy |
| Jul-12-19 | Upgrade | Citigroup | Neutral → Buy |
| Apr-18-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Morgan Stanley Stock (MS) Latest News
Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement - marketbeat.com
Morgan Stanley Lifts M&T Bank As Financials Slip - Finimize
Carry Trades Can Withstand Yen Strength, Morgan Stanley Says - Bloomberg.com
Goldman Stock Gains 38.6% in a Year: Buy Now or Wait for a Pullback? - Zacks Investment Research
Pinnacle Financial Partners Positioned to Outgrow Peers After Synovus Merger, Morgan Stanley Says - marketscreener.com
Adobe Should Use Q3 Results to Boost Visibility Into Fiscal 2027 Monetization, Morgan Stanley Says - marketscreener.com
M&T Bank Poised for $2.9 Billion in 2027 Buybacks, Topping Consensus, Morgan Stanley Says - marketscreener.com
First Horizon Well-Positioned for Organic Growth, Morgan Stanley Says - marketscreener.com
Morgan Stanley Wants Adobe To Show A 2027 ARR Turnaround - Finimize
Morgan Stanley Sees Peloton Subscribers Shrinking As Gyms Win Back Fans - Finimize
Morgan Stanley Sees First Horizon As A ROTCE Rebound Story - Finimize
Morgan Stanley Sees Pinnacle’s Synovus Deal Powering Faster Growth - Finimize
Morgan Stanley turns more selective on European chip stocks - Investing.com
REGMorgan Stanley B.V.ISMMSBV- PARTIAL_RETIREMENT -08-09-2026 - TradingView
M&T Bank upgraded to Buy-equivalent at Morgan Stanley, named Top Pick (MTB:NYSE) - Seeking Alpha
Pfizer CEO Albert Bourla will speak at Morgan Stanley's healthcare conference Sept. 14 - Stock Titan
Oracle jumps 5% as Morgan Stanley raises price target, boosting AI cloud infrastructure stocks. - pluang.com
Beneath the surface, the next stock-market leaders are getting ready to break out, says Morgan Stanley - marketwatch.com
Morgan Stanley Upgrades M&T Bank to Overweight From Equalweight, Adjusts PT to $304 From $253 - marketscreener.com
Morgan Stanley Initiates First Horizon at Equalweight With $30 Price Target - marketscreener.com
Oracle Rallies 5% as Morgan Stanley Lifts Its Price Target, CoreWeave Advances 3% - 24/7 Wall St.
Central Bancompany (NASDAQ:CBC) Downgraded by Morgan Stanley to Equal Weight - marketbeat.com
Zions Bancorporation, N.A. (NASDAQ:ZION) Downgraded by Morgan Stanley to "Underweight" - marketbeat.com
Simmons First National (NASDAQ:SFNC) Downgraded by Morgan Stanley to "Underweight" - marketbeat.com
Morgan Stanley Downgrades Infineon Technologies to Equalweight, Cuts PT - Moomoo
Amylyx will go live Sept. 15 for a Morgan Stanley healthcare event - Stock Titan
Morgan Stanley: AI Investment Returns Reach Up to 46%; Capex Growth to Slam the Brakes in 2028 - finance.biggo.com
Peloton slides after Morgan Stanley issues a bear call (PTON:NASDAQ) - Seeking Alpha
Eurofins Scientific Downgraded by Morgan Stanley - marketscreener.com
Morgan Stanley upgrades Synopsys, cuts Infineon; 'time to be more selective' (SNPS:NASDAQ) - Seeking Alpha
Morgan Stanley upgrades Synopsys as it turns selective on chip stocks - Investing.com Canada
Morgan Stanley will host Vericel at a healthcare conference Sept. 15 - Stock Titan
Morgan Stanley's healthcare conference will feature CRISPR Therapeutics on Sept. 14 - Stock Titan
Anthropic Nears Decision on Banks for Potential $2 Trillion IPO - Banking Exchange
Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026 - marketscreener.com
CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewswire
Anthropic Taps Morgan Stanley and Goldman Sachs for Its $2 Trillion IPO - Pasquale Pillitteri
Morgan Stanley cuts Peloton rating on structural fitness headwinds By Investing.com - Investing.com Nigeria
Walden Biosciences to Participate in 24th Annual Morgan Stanley Global Healthcare Conference - GlobeNewswire
Morgan Stanley cuts Peloton rating on structural fitness headwinds - Investing.com
Morgan Stanley cuts Onto Innovation stock price target on mix dynamics - Investing.com
Morgan Stanley Downgrades Customers Bancorp to Underweight From Equalweight, Adjusts PT to $89 From $88 - marketscreener.com
Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewswire
Morgan Stanley reiterates Grindr stock rating on monetization potential - Investing.com
Merck's CEO and research chief will speak online Sept. 14 - Stock Titan
Merck to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - businesswire.com
Morgan Stanley's Long Position In Shares Of Cathay Pacific Airways Increases To 7.19% On Sept 3 From 6.31%, Says HKEX - TradingView
Morgan Stanley Initiates PDF Solutions at Overweight With $62 Price Target - marketscreener.com
Morgan Stanley, Goldman Sachs Near Lead Roles in Anthropic’s Potential $2 Trillion - citybiz
Morgan Stanley Upgrades Synopsys to Overweight From Equalweight, Price Target is $500 - marketscreener.com
Morgan Stanley upgrades Synopsys stock rating on Ansys integration - Investing.com
Morgan Stanley Stock (MS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):